Literature DB >> 22224561

Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation.

Marielle J Wondergem, Josee M Zijlstra, Madelon de Rooij, Otto J Visser, Peter C Huijgens, Sonja Zweegman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22224561     DOI： 10.1111/j.1365-2141.2011.08991.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Long-term follow-up of (90)Y-ibritumomab-tiuxetan ((90)YIT) in the conditioning of autologous hematopoietic transplantation for indolent and mantle cell lymphomas in a single French center.

Authors:  L Philippe; P Helias; M Puyraveau; H Boulahdour; E Deconinck; E Daguindau
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

2.  Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane.

Authors:  Kashif Jilani; Florian Lang
Journal:  Toxins (Basel)       Date:  2013-04-19       Impact factor: 4.546

Review 3.  Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis.

Authors:  Sophie Auger-Quittet; Yohan Duny; Jean-Pierre Daures; Philipe Quittet
Journal:  Cancer Med       Date:  2014-04-16       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.